Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001677036-26-000002

Options or other derivatives

  • Director acquired 1,370 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Lind Kevin Robert Director 2026-03-31 Grant or award · Stock Option (Right to Buy) +1,370 $12.13 $16,618 1,370 D
Loading xslF345X06/form4-04012026_040408.xml…